Kindler HL, Hammel P, Michele Reni, et al. Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial. ASCO Annual Meeting 2019, abstract LBA4.
Verbeterde overleving bij EGFR-gemuteerd NSCLC: nieuw behandelperspectief
mei 2025 | Longoncologie